id	sid	tid	token	lemma	pos
ffhd-1631	1	1	seaberry	seaberry	VERB
ffhd-1631	1	2	ursolic	ursolic	ADJ
ffhd-1631	1	3	acid	acid	NOUN
ffhd-1631	1	4	improves	improve	VERB
ffhd-1631	1	5	daytime	daytime	ADJ
ffhd-1631	1	6	frequency	frequency	NOUN
ffhd-1631	1	7	and	and	CCONJ
ffhd-1631	1	8	urgency	urgency	NOUN
ffhd-1631	1	9	of	of	ADP
ffhd-1631	1	10	urination	urination	NOUN
ffhd-1631	1	11	in	in	ADP
ffhd-1631	1	12	healthy	healthy	ADJ
ffhd-1631	1	13	japanese	japanese	ADJ
ffhd-1631	1	14	subjects	subject	NOUN
ffhd-1631	1	15	:	:	PUNCT
ffhd-1631	1	16	a	a	DET
ffhd-1631	1	17	randomized	randomized	ADJ
ffhd-1631	1	18	,	,	PUNCT
ffhd-1631	1	19	placebo	placebo	NOUN
ffhd-1631	1	20	-	-	PUNCT
ffhd-1631	1	21	controlled	control	VERB
ffhd-1631	1	22	,	,	PUNCT
ffhd-1631	1	23	double	double	ADJ
ffhd-1631	1	24	-	-	PUNCT
ffhd-1631	1	25	blind	blind	ADJ
ffhd-1631	1	26	trial	trial	NOUN
ffhd-1631	1	27	|	|	ADV
ffhd-1631	1	28	functional	functional	ADJ
ffhd-1631	1	29	foods	food	NOUN
ffhd-1631	1	30	in	in	ADP
ffhd-1631	1	31	health	health	NOUN
ffhd-1631	1	32	and	and	CCONJ
ffhd-1631	1	33	disease	disease	PROPN
ffhd-1631	1	34	online	online	PROPN
ffhd-1631	1	35	issn	issn	PROPN
ffhd-1631	1	36	:	:	PUNCT
ffhd-1631	1	37	2160	2160	NUM
ffhd-1631	1	38	-	-	SYM
ffhd-1631	1	39	3855	3855	NUM
ffhd-1631	1	40	;	;	PUNCT
ffhd-1631	1	41	print	print	NOUN
ffhd-1631	1	42	issn	issn	PROPN
ffhd-1631	1	43	:	:	PUNCT
ffhd-1631	1	44	2378	2378	NUM
ffhd-1631	1	45	-	-	SYM
ffhd-1631	1	46	7007	7007	NUM
ffhd-1631	1	47	skip	skip	NOUN
ffhd-1631	1	48	to	to	ADP
ffhd-1631	1	49	main	main	ADJ
ffhd-1631	1	50	content	content	NOUN
ffhd-1631	1	51	skip	skip	ADJ
ffhd-1631	1	52	to	to	ADP
ffhd-1631	1	53	main	main	ADJ
ffhd-1631	1	54	navigation	navigation	NOUN
ffhd-1631	1	55	menu	menu	NOUN
ffhd-1631	1	56	skip	skip	VERB
ffhd-1631	1	57	to	to	PART
ffhd-1631	1	58	site	site	VERB
ffhd-1631	1	59	footer	footer	ADJ
ffhd-1631	1	60	open	open	ADJ
ffhd-1631	1	61	menu	menu	NOUN
ffhd-1631	1	62	functional	functional	ADJ
ffhd-1631	1	63	foods	food	NOUN
ffhd-1631	1	64	in	in	ADP
ffhd-1631	1	65	health	health	NOUN
ffhd-1631	1	66	and	and	CCONJ
ffhd-1631	1	67	disease	disease	PROPN
ffhd-1631	1	68	online	online	PROPN
ffhd-1631	1	69	issn	issn	PROPN
ffhd-1631	1	70	:	:	PUNCT
ffhd-1631	1	71	2160	2160	NUM
ffhd-1631	1	72	-	-	SYM
ffhd-1631	1	73	3855	3855	NUM
ffhd-1631	1	74	;	;	PUNCT
ffhd-1631	1	75	print	print	NOUN
ffhd-1631	1	76	issn	issn	PROPN
ffhd-1631	1	77	:	:	PUNCT
ffhd-1631	1	78	2378	2378	NUM
ffhd-1631	1	79	-	-	SYM
ffhd-1631	1	80	7007	7007	NUM
ffhd-1631	1	81	home	home	NOUN
ffhd-1631	1	82	food	food	NOUN
ffhd-1631	1	83	science	science	NOUN
ffhd-1631	1	84	publisher	publisher	NOUN
ffhd-1631	1	85	functional	functional	ADJ
ffhd-1631	1	86	food	food	NOUN
ffhd-1631	1	87	center	center	NOUN
ffhd-1631	1	88	current	current	ADJ
ffhd-1631	1	89	archives	archive	NOUN
ffhd-1631	1	90	about	about	ADP
ffhd-1631	1	91	about	about	ADP
ffhd-1631	1	92	the	the	DET
ffhd-1631	1	93	journal	journal	NOUN
ffhd-1631	1	94	aims	aim	VERB
ffhd-1631	1	95	and	and	CCONJ
ffhd-1631	1	96	scope	scope	NOUN
ffhd-1631	1	97	contact	contact	NOUN
ffhd-1631	1	98	editing	edit	VERB
ffhd-1631	1	99	services	service	NOUN
ffhd-1631	1	100	editorial	editorial	ADJ
ffhd-1631	1	101	team	team	NOUN
ffhd-1631	1	102	express	express	VERB
ffhd-1631	1	103	peer	peer	NOUN
ffhd-1631	1	104	review	review	NOUN
ffhd-1631	1	105	graphical	graphical	ADJ
ffhd-1631	1	106	abstract	abstract	ADJ
ffhd-1631	1	107	journal	journal	NOUN
ffhd-1631	1	108	insights	insight	VERB
ffhd-1631	1	109	privacy	privacy	NOUN
ffhd-1631	1	110	statement	statement	NOUN
ffhd-1631	1	111	submissions	submission	NOUN
ffhd-1631	1	112	announcements	announcement	NOUN
ffhd-1631	1	113	search	search	NOUN
ffhd-1631	1	114	search	search	NOUN
ffhd-1631	1	115	register	register	NOUN
ffhd-1631	1	116	login	login	NOUN
ffhd-1631	1	117	home	home	NOUN
ffhd-1631	1	118	/	/	SYM
ffhd-1631	1	119	archives	archive	NOUN
ffhd-1631	1	120	/	/	SYM
ffhd-1631	1	121	vol	vol	NOUN
ffhd-1631	1	122	.	.	PROPN
ffhd-1631	1	123	15	15	NUM
ffhd-1631	2	1	no	no	NOUN
ffhd-1631	2	2	.	.	NOUN
ffhd-1631	2	3	6	6	NUM
ffhd-1631	2	4	(	(	PUNCT
ffhd-1631	2	5	2025	2025	NUM
ffhd-1631	2	6	):	):	PUNCT
ffhd-1631	2	7	june	june	PROPN
ffhd-1631	2	8	2025	2025	NUM
ffhd-1631	2	9	/	/	SYM
ffhd-1631	2	10	research	research	NOUN
ffhd-1631	2	11	articles	article	NOUN
ffhd-1631	2	12	seaberry	seaberry	VERB
ffhd-1631	2	13	ursolic	ursolic	ADJ
ffhd-1631	2	14	acid	acid	NOUN
ffhd-1631	2	15	improves	improve	VERB
ffhd-1631	2	16	daytime	daytime	ADJ
ffhd-1631	2	17	frequency	frequency	NOUN
ffhd-1631	2	18	and	and	CCONJ
ffhd-1631	2	19	urgency	urgency	NOUN
ffhd-1631	2	20	of	of	ADP
ffhd-1631	2	21	urination	urination	NOUN
ffhd-1631	2	22	in	in	ADP
ffhd-1631	2	23	healthy	healthy	ADJ
ffhd-1631	2	24	japanese	japanese	ADJ
ffhd-1631	2	25	subjects	subject	NOUN
ffhd-1631	2	26	:	:	PUNCT
ffhd-1631	2	27	a	a	DET
ffhd-1631	2	28	randomized	randomized	ADJ
ffhd-1631	2	29	,	,	PUNCT
ffhd-1631	2	30	placebo	placebo	NOUN
ffhd-1631	2	31	-	-	PUNCT
ffhd-1631	2	32	controlled	control	VERB
ffhd-1631	2	33	,	,	PUNCT
ffhd-1631	2	34	double	double	ADJ
ffhd-1631	2	35	-	-	PUNCT
ffhd-1631	2	36	blind	blind	ADJ
ffhd-1631	2	37	trial	trial	NOUN
ffhd-1631	2	38	authors	author	NOUN
ffhd-1631	2	39	norihito	norihito	PROPN
ffhd-1631	2	40	shimizu	shimizu	PROPN
ffhd-1631	2	41	ryoma	ryoma	PROPN
ffhd-1631	2	42	shimizu	shimizu	PROPN
ffhd-1631	2	43	masahiro	masahiro	PROPN
ffhd-1631	2	44	yagihashi	yagihashi	PROPN
ffhd-1631	2	45	kazunori	kazunori	PROPN
ffhd-1631	2	46	goto	goto	PROPN
ffhd-1631	2	47	hiroshi	hiroshi	PROPN
ffhd-1631	2	48	shimoda	shimoda	PROPN
ffhd-1631	2	49	marina	marina	PROPN
ffhd-1631	2	50	hirano	hirano	PROPN
ffhd-1631	2	51	hiroyuki	hiroyuki	PROPN
ffhd-1631	2	52	shimizu	shimizu	PROPN
ffhd-1631	2	53	shizuo	shizuo	PROPN
ffhd-1631	2	54	yamada	yamada	PROPN
ffhd-1631	2	55	doi	doi	PROPN
ffhd-1631	2	56	:	:	PUNCT
ffhd-1631	2	57	https://doi.org/10.31989/ffhd.v15i6.1631	https://doi.org/10.31989/ffhd.v15i6.1631	NUM
ffhd-1631	2	58	abstract	abstract	ADJ
ffhd-1631	2	59	background	background	NOUN
ffhd-1631	2	60	and	and	CCONJ
ffhd-1631	2	61	objective	objective	NOUN
ffhd-1631	2	62	:	:	PUNCT
ffhd-1631	2	63	the	the	DET
ffhd-1631	2	64	fruit	fruit	NOUN
ffhd-1631	2	65	of	of	ADP
ffhd-1631	2	66	seaberry	seaberry	NOUN
ffhd-1631	2	67	(	(	PUNCT
ffhd-1631	2	68	hippophae	hippophae	ADV
ffhd-1631	2	69	rhamnoides	rhamnoide	NOUN
ffhd-1631	2	70	)	)	PUNCT
ffhd-1631	2	71	,	,	PUNCT
ffhd-1631	2	72	which	which	PRON
ffhd-1631	2	73	exerts	exert	VERB
ffhd-1631	2	74	 	 	SPACE
ffhd-1631	2	75	anti	anti	ADJ
ffhd-1631	2	76	-	-	ADJ
ffhd-1631	2	77	hypertensive	hypertensive	ADJ
ffhd-1631	2	78	,	,	PUNCT
ffhd-1631	2	79	hypoglycemic	hypoglycemic	ADJ
ffhd-1631	2	80	,	,	PUNCT
ffhd-1631	2	81	anti	anti	ADJ
ffhd-1631	2	82	-	-	NOUN
ffhd-1631	2	83	obesity	obesity	NOUN
ffhd-1631	2	84	,	,	PUNCT
ffhd-1631	2	85	and	and	CCONJ
ffhd-1631	2	86	immunomodulatory	immunomodulatory	ADJ
ffhd-1631	2	87	effects	effect	NOUN
ffhd-1631	2	88	,	,	PUNCT
ffhd-1631	2	89	contains	contain	VERB
ffhd-1631	2	90	triterpenoids	triterpenoid	NOUN
ffhd-1631	2	91	,	,	PUNCT
ffhd-1631	2	92	namely	namely	ADV
ffhd-1631	2	93	ursolic	ursolic	ADJ
ffhd-1631	2	94	acid	acid	NOUN
ffhd-1631	2	95	.	.	PUNCT
ffhd-1631	3	1	we	we	PRON
ffhd-1631	3	2	previously	previously	ADV
ffhd-1631	3	3	reported	report	VERB
ffhd-1631	3	4	that	that	SCONJ
ffhd-1631	3	5	seaberry	seaberry	NOUN
ffhd-1631	3	6	-	-	PUNCT
ffhd-1631	3	7	derived	derive	VERB
ffhd-1631	3	8	ursolic	ursolic	ADJ
ffhd-1631	3	9	acid	acid	NOUN
ffhd-1631	3	10	suppressed	suppress	VERB
ffhd-1631	3	11	urination	urination	NOUN
ffhd-1631	3	12	frequency	frequency	NOUN
ffhd-1631	3	13	and	and	CCONJ
ffhd-1631	3	14	anxiety	anxiety	NOUN
ffhd-1631	3	15	related	relate	VERB
ffhd-1631	3	16	to	to	ADP
ffhd-1631	3	17	urination	urination	NOUN
ffhd-1631	3	18	in	in	ADP
ffhd-1631	3	19	japanese	japanese	ADJ
ffhd-1631	3	20	subjects	subject	NOUN
ffhd-1631	3	21	;	;	PUNCT
ffhd-1631	3	22	however	however	ADV
ffhd-1631	3	23	,	,	PUNCT
ffhd-1631	3	24	some	some	DET
ffhd-1631	3	25	subjects	subject	NOUN
ffhd-1631	3	26	were	be	AUX
ffhd-1631	3	27	patients	patient	NOUN
ffhd-1631	3	28	with	with	ADP
ffhd-1631	3	29	mild	mild	ADJ
ffhd-1631	3	30	overactive	overactive	ADJ
ffhd-1631	3	31	bladder	bladder	NOUN
ffhd-1631	3	32	(	(	PUNCT
ffhd-1631	3	33	oab	oab	PROPN
ffhd-1631	3	34	)	)	PUNCT
ffhd-1631	3	35	.	.	PUNCT
ffhd-1631	4	1	therefore	therefore	ADV
ffhd-1631	4	2	,	,	PUNCT
ffhd-1631	4	3	we	we	PRON
ffhd-1631	4	4	conducted	conduct	VERB
ffhd-1631	4	5	a	a	DET
ffhd-1631	4	6	clinical	clinical	ADJ
ffhd-1631	4	7	trial	trial	NOUN
ffhd-1631	4	8	on	on	ADP
ffhd-1631	4	9	the	the	DET
ffhd-1631	4	10	effects	effect	NOUN
ffhd-1631	4	11	of	of	ADP
ffhd-1631	4	12	ursolic	ursolic	ADJ
ffhd-1631	4	13	acid	acid	NOUN
ffhd-1631	4	14	supplementation	supplementation	NOUN
ffhd-1631	4	15	on	on	ADP
ffhd-1631	4	16	urination	urination	NOUN
ffhd-1631	4	17	frequency	frequency	NOUN
ffhd-1631	4	18	and	and	CCONJ
ffhd-1631	4	19	urination	urination	NOUN
ffhd-1631	4	20	scores	score	NOUN
ffhd-1631	4	21	in	in	ADP
ffhd-1631	4	22	healthy	healthy	ADJ
ffhd-1631	4	23	japanese	japanese	ADJ
ffhd-1631	4	24	subjects	subject	NOUN
ffhd-1631	4	25	.	.	PUNCT
ffhd-1631	4	26	  	  	SPACE
ffhd-1631	4	27	methods	method	NOUN
ffhd-1631	4	28	:	:	PUNCT
ffhd-1631	4	29	eighty	eighty	NUM
ffhd-1631	4	30	out	out	ADP
ffhd-1631	4	31	of	of	ADP
ffhd-1631	4	32	256	256	NUM
ffhd-1631	4	33	registered	register	VERB
ffhd-1631	4	34	volunteers	volunteer	NOUN
ffhd-1631	4	35	were	be	AUX
ffhd-1631	4	36	enrolled	enrol	VERB
ffhd-1631	4	37	in	in	ADP
ffhd-1631	4	38	the	the	DET
ffhd-1631	4	39	present	present	ADJ
ffhd-1631	4	40	study	study	NOUN
ffhd-1631	4	41	.	.	PUNCT
ffhd-1631	5	1	this	this	PRON
ffhd-1631	5	2	was	be	AUX
ffhd-1631	5	3	a	a	DET
ffhd-1631	5	4	randomized	randomized	ADJ
ffhd-1631	5	5	,	,	PUNCT
ffhd-1631	5	6	placebo	placebo	NOUN
ffhd-1631	5	7	-	-	PUNCT
ffhd-1631	5	8	controlled	control	VERB
ffhd-1631	5	9	,	,	PUNCT
ffhd-1631	5	10	double	double	ADJ
ffhd-1631	5	11	-	-	PUNCT
ffhd-1631	5	12	blind	blind	ADJ
ffhd-1631	5	13	study	study	NOUN
ffhd-1631	5	14	.	.	PUNCT
ffhd-1631	6	1	all	all	DET
ffhd-1631	6	2	subjects	subject	NOUN
ffhd-1631	6	3	were	be	AUX
ffhd-1631	6	4	randomly	randomly	ADV
ffhd-1631	6	5	allocated	allocate	VERB
ffhd-1631	6	6	by	by	ADP
ffhd-1631	6	7	the	the	DET
ffhd-1631	6	8	stratified	stratified	ADJ
ffhd-1631	6	9	block	block	NOUN
ffhd-1631	6	10	randomization	randomization	NOUN
ffhd-1631	6	11	method	method	NOUN
ffhd-1631	6	12	into	into	ADP
ffhd-1631	6	13	the	the	DET
ffhd-1631	6	14	ursolic	ursolic	ADJ
ffhd-1631	6	15	acid	acid	NOUN
ffhd-1631	6	16	group	group	NOUN
ffhd-1631	6	17	(	(	PUNCT
ffhd-1631	6	18	n=40	n=40	ADJ
ffhd-1631	6	19	)	)	PUNCT
ffhd-1631	6	20	or	or	CCONJ
ffhd-1631	6	21	placebo	placebo	NOUN
ffhd-1631	6	22	group	group	NOUN
ffhd-1631	6	23	(	(	PUNCT
ffhd-1631	6	24	n=40	n=40	ADJ
ffhd-1631	6	25	)	)	PUNCT
ffhd-1631	6	26	.	.	PUNCT
ffhd-1631	7	1	tablets	tablet	NOUN
ffhd-1631	7	2	containing	contain	VERB
ffhd-1631	7	3	ursolic	ursolic	ADJ
ffhd-1631	7	4	acid	acid	NOUN
ffhd-1631	7	5	(	(	PUNCT
ffhd-1631	7	6	0.2	0.2	NUM
ffhd-1631	7	7	mg	mg	NOUN
ffhd-1631	7	8	/	/	SYM
ffhd-1631	7	9	day	day	NOUN
ffhd-1631	7	10	)	)	PUNCT
ffhd-1631	7	11	or	or	CCONJ
ffhd-1631	7	12	placebo	placebo	NOUN
ffhd-1631	7	13	were	be	AUX
ffhd-1631	7	14	administered	administer	VERB
ffhd-1631	7	15	for	for	ADP
ffhd-1631	7	16	8	8	NUM
ffhd-1631	7	17	weeks	week	NOUN
ffhd-1631	7	18	between	between	ADP
ffhd-1631	7	19	january	january	PROPN
ffhd-1631	7	20	and	and	CCONJ
ffhd-1631	7	21	march	march	PROPN
ffhd-1631	7	22	2024	2024	NUM
ffhd-1631	7	23	.	.	PUNCT
ffhd-1631	8	1	a	a	DET
ffhd-1631	8	2	voiding	void	VERB
ffhd-1631	8	3	diary	diary	NOUN
ffhd-1631	8	4	and	and	CCONJ
ffhd-1631	8	5	the	the	DET
ffhd-1631	8	6	core	core	NOUN
ffhd-1631	8	7	lower	low	ADJ
ffhd-1631	8	8	urinary	urinary	ADJ
ffhd-1631	8	9	tract	tract	NOUN
ffhd-1631	8	10	symptom	symptom	NOUN
ffhd-1631	8	11	score	score	NOUN
ffhd-1631	8	12	(	(	PUNCT
ffhd-1631	8	13	clss	clss	PROPN
ffhd-1631	8	14	)	)	PUNCT
ffhd-1631	8	15	were	be	AUX
ffhd-1631	8	16	the	the	DET
ffhd-1631	8	17	primary	primary	ADJ
ffhd-1631	8	18	outcomes	outcome	NOUN
ffhd-1631	8	19	.	.	PUNCT
ffhd-1631	9	1	the	the	DET
ffhd-1631	9	2	secondary	secondary	ADJ
ffhd-1631	9	3	outcomes	outcome	NOUN
ffhd-1631	9	4	were	be	AUX
ffhd-1631	9	5	the	the	DET
ffhd-1631	9	6	oab	oab	PROPN
ffhd-1631	9	7	and	and	CCONJ
ffhd-1631	9	8	king	king	NOUN
ffhd-1631	9	9	’s	’s	PART
ffhd-1631	9	10	health	health	NOUN
ffhd-1631	9	11	questionnaire	questionnaire	NOUN
ffhd-1631	9	12	(	(	PUNCT
ffhd-1631	9	13	khq	khq	NOUN
ffhd-1631	9	14	)	)	PUNCT
ffhd-1631	9	15	.	.	PUNCT
ffhd-1631	10	1	a	a	DET
ffhd-1631	10	2	safety	safety	NOUN
ffhd-1631	10	3	analysis	analysis	NOUN
ffhd-1631	10	4	measured	measure	VERB
ffhd-1631	10	5	blood	blood	NOUN
ffhd-1631	10	6	,	,	PUNCT
ffhd-1631	10	7	urine	urine	NOUN
ffhd-1631	10	8	,	,	PUNCT
ffhd-1631	10	9	and	and	CCONJ
ffhd-1631	10	10	other	other	ADJ
ffhd-1631	10	11	body	body	NOUN
ffhd-1631	10	12	parameters	parameter	NOUN
ffhd-1631	10	13	.	.	PUNCT
ffhd-1631	10	14	  	  	SPACE
ffhd-1631	10	15	results	result	VERB
ffhd-1631	10	16	:	:	PUNCT
ffhd-1631	10	17	the	the	DET
ffhd-1631	10	18	per	per	ADP
ffhd-1631	10	19	-	-	PUNCT
ffhd-1631	10	20	protocol	protocol	NOUN
ffhd-1631	10	21	set	set	NOUN
ffhd-1631	10	22	comprised	comprise	VERB
ffhd-1631	10	23	35	35	NUM
ffhd-1631	10	24	subjects	subject	NOUN
ffhd-1631	10	25	in	in	ADP
ffhd-1631	10	26	the	the	DET
ffhd-1631	10	27	ursolic	ursolic	ADJ
ffhd-1631	10	28	acid	acid	NOUN
ffhd-1631	10	29	group	group	NOUN
ffhd-1631	10	30	and	and	CCONJ
ffhd-1631	10	31	32	32	NUM
ffhd-1631	10	32	in	in	ADP
ffhd-1631	10	33	the	the	DET
ffhd-1631	10	34	placebo	placebo	NOUN
ffhd-1631	10	35	group	group	NOUN
ffhd-1631	10	36	.	.	PUNCT
ffhd-1631	11	1	daytime	daytime	ADJ
ffhd-1631	11	2	urination	urination	PROPN
ffhd-1631	11	3	frequency	frequency	NOUN
ffhd-1631	11	4	significantly	significantly	ADV
ffhd-1631	11	5	decreased	decrease	VERB
ffhd-1631	11	6	after	after	ADP
ffhd-1631	11	7	3	3	NUM
ffhd-1631	11	8	weeks	week	NOUN
ffhd-1631	11	9	of	of	ADP
ffhd-1631	11	10	ursolic	ursolic	ADJ
ffhd-1631	11	11	acid	acid	NOUN
ffhd-1631	11	12	supplementation	supplementation	NOUN
ffhd-1631	11	13	,	,	PUNCT
ffhd-1631	11	14	and	and	CCONJ
ffhd-1631	11	15	a	a	DET
ffhd-1631	11	16	significant	significant	ADJ
ffhd-1631	11	17	correlation	correlation	NOUN
ffhd-1631	11	18	between	between	ADP
ffhd-1631	11	19	the	the	DET
ffhd-1631	11	20	number	number	NOUN
ffhd-1631	11	21	of	of	ADP
ffhd-1631	11	22	daytime	daytime	ADJ
ffhd-1631	11	23	urinations	urination	NOUN
ffhd-1631	11	24	and	and	CCONJ
ffhd-1631	11	25	time	time	NOUN
ffhd-1631	11	26	was	be	AUX
ffhd-1631	11	27	detected	detect	VERB
ffhd-1631	11	28	in	in	ADP
ffhd-1631	11	29	the	the	DET
ffhd-1631	11	30	ursolic	ursolic	ADJ
ffhd-1631	11	31	acid	acid	NOUN
ffhd-1631	11	32	group	group	NOUN
ffhd-1631	11	33	.	.	PUNCT
ffhd-1631	12	1	no	no	DET
ffhd-1631	12	2	significant	significant	ADJ
ffhd-1631	12	3	differences	difference	NOUN
ffhd-1631	12	4	were	be	AUX
ffhd-1631	12	5	observed	observe	VERB
ffhd-1631	12	6	in	in	ADP
ffhd-1631	12	7	other	other	ADJ
ffhd-1631	12	8	scores	score	NOUN
ffhd-1631	12	9	or	or	CCONJ
ffhd-1631	12	10	parameters	parameter	NOUN
ffhd-1631	12	11	in	in	ADP
ffhd-1631	12	12	the	the	DET
ffhd-1631	12	13	safety	safety	NOUN
ffhd-1631	12	14	analysis	analysis	NOUN
ffhd-1631	12	15	.	.	PUNCT
ffhd-1631	13	1	conclusions	conclusion	NOUN
ffhd-1631	13	2	:	:	PUNCT
ffhd-1631	13	3	the	the	DET
ffhd-1631	13	4	intake	intake	NOUN
ffhd-1631	13	5	of	of	ADP
ffhd-1631	13	6	ursolic	ursolic	ADJ
ffhd-1631	13	7	acid	acid	NOUN
ffhd-1631	13	8	(	(	PUNCT
ffhd-1631	13	9	0.2	0.2	NUM
ffhd-1631	13	10	mg	mg	NOUN
ffhd-1631	13	11	/	/	SYM
ffhd-1631	13	12	day	day	NOUN
ffhd-1631	13	13	)	)	PUNCT
ffhd-1631	13	14	reduced	reduce	VERB
ffhd-1631	13	15	daytime	daytime	ADJ
ffhd-1631	13	16	urination	urination	NOUN
ffhd-1631	13	17	frequency	frequency	NOUN
ffhd-1631	13	18	and	and	CCONJ
ffhd-1631	13	19	urgency	urgency	NOUN
ffhd-1631	13	20	.	.	PUNCT
ffhd-1631	14	1	therefore	therefore	ADV
ffhd-1631	14	2	,	,	PUNCT
ffhd-1631	14	3	seaberry	seaberry	VERB
ffhd-1631	14	4	ursolic	ursolic	ADJ
ffhd-1631	14	5	acid	acid	NOUN
ffhd-1631	14	6	can	can	AUX
ffhd-1631	14	7	potentially	potentially	ADV
ffhd-1631	14	8	manage	manage	VERB
ffhd-1631	14	9	urgent	urgent	ADJ
ffhd-1631	14	10	urination	urination	NOUN
ffhd-1631	14	11	in	in	ADP
ffhd-1631	14	12	healthy	healthy	ADJ
ffhd-1631	14	13	subjects	subject	NOUN
ffhd-1631	14	14	.	.	PUNCT
ffhd-1631	15	1	novelty	novelty	NOUN
ffhd-1631	15	2	:	:	PUNCT
ffhd-1631	16	1	this	this	DET
ffhd-1631	16	2	study	study	NOUN
ffhd-1631	16	3	presents	present	VERB
ffhd-1631	16	4	the	the	DET
ffhd-1631	16	5	novel	novel	NOUN
ffhd-1631	16	6	finding	finding	NOUN
ffhd-1631	16	7	that	that	SCONJ
ffhd-1631	16	8	a	a	DET
ffhd-1631	16	9	low	low	ADV
ffhd-1631	16	10	-	-	PUNCT
ffhd-1631	16	11	dose	dose	NOUN
ffhd-1631	16	12	(	(	PUNCT
ffhd-1631	16	13	0.2	0.2	NUM
ffhd-1631	16	14	mg	mg	NOUN
ffhd-1631	16	15	/	/	SYM
ffhd-1631	16	16	day	day	NOUN
ffhd-1631	16	17	)	)	PUNCT
ffhd-1631	16	18	ursolic	ursolic	ADJ
ffhd-1631	16	19	acid	acid	NOUN
ffhd-1631	16	20	supplementation	supplementation	NOUN
ffhd-1631	16	21	derived	derive	VERB
ffhd-1631	16	22	from	from	ADP
ffhd-1631	16	23	seaberry	seaberry	NOUN
ffhd-1631	16	24	significantly	significantly	ADV
ffhd-1631	16	25	reduces	reduce	VERB
ffhd-1631	16	26	daytime	daytime	ADJ
ffhd-1631	16	27	urination	urination	NOUN
ffhd-1631	16	28	frequency	frequency	NOUN
ffhd-1631	16	29	after	after	ADP
ffhd-1631	16	30	3	3	NUM
ffhd-1631	16	31	weeks	week	NOUN
ffhd-1631	16	32	and	and	CCONJ
ffhd-1631	16	33	the	the	DET
ffhd-1631	16	34	urgency	urgency	NOUN
ffhd-1631	16	35	of	of	ADP
ffhd-1631	16	36	urination	urination	NOUN
ffhd-1631	16	37	in	in	ADP
ffhd-1631	16	38	a	a	DET
ffhd-1631	16	39	randomized	randomized	ADJ
ffhd-1631	16	40	,	,	PUNCT
ffhd-1631	16	41	placebo	placebo	NOUN
ffhd-1631	16	42	-	-	PUNCT
ffhd-1631	16	43	controlled	control	VERB
ffhd-1631	16	44	,	,	PUNCT
ffhd-1631	16	45	double	double	ADJ
ffhd-1631	16	46	-	-	PUNCT
ffhd-1631	16	47	blind	blind	ADJ
ffhd-1631	16	48	clinical	clinical	ADJ
ffhd-1631	16	49	trial	trial	NOUN
ffhd-1631	16	50	conducted	conduct	VERB
ffhd-1631	16	51	explicitly	explicitly	ADV
ffhd-1631	16	52	on	on	ADP
ffhd-1631	16	53	healthy	healthy	ADJ
ffhd-1631	16	54	japanese	japanese	ADJ
ffhd-1631	16	55	adults	adult	NOUN
ffhd-1631	16	56	.	.	PUNCT
ffhd-1631	17	1	trial	trial	NOUN
ffhd-1631	17	2	registration	registration	NOUN
ffhd-1631	17	3	:	:	PUNCT
ffhd-1631	17	4	umin	umin	PROPN
ffhd-1631	17	5	-	-	PUNCT
ffhd-1631	17	6	ctr	ctr	PROPN
ffhd-1631	17	7	:	:	PUNCT
ffhd-1631	17	8	umin000052848	umin000052848	PROPN
ffhd-1631	17	9	foundation	foundation	NOUN
ffhd-1631	17	10	:	:	PUNCT
ffhd-1631	17	11	oryza	oryza	PROPN
ffhd-1631	17	12	oil	oil	PROPN
ffhd-1631	17	13	&	&	CCONJ
ffhd-1631	17	14	fat	fat	PROPN
ffhd-1631	17	15	chemical	chemical	PROPN
ffhd-1631	17	16	co.	co.	PROPN
ffhd-1631	17	17	,	,	PUNCT
ffhd-1631	17	18	ltd	ltd	PROPN
ffhd-1631	17	19	.	.	PROPN
ffhd-1631	18	1	keywords	keyword	NOUN
ffhd-1631	18	2	:	:	PUNCT
ffhd-1631	18	3	ursolic	ursolic	ADJ
ffhd-1631	18	4	acid	acid	NOUN
ffhd-1631	18	5	;	;	PUNCT
ffhd-1631	18	6	seaberry	seaberry	NOUN
ffhd-1631	18	7	;	;	PUNCT
ffhd-1631	18	8	urination	urination	NOUN
ffhd-1631	18	9	;	;	PUNCT
ffhd-1631	18	10	overactive	overactive	ADJ
ffhd-1631	18	11	bladder	bladder	NOUN
ffhd-1631	18	12	;	;	PUNCT
ffhd-1631	18	13	core	core	NOUN
ffhd-1631	18	14	lower	low	ADJ
ffhd-1631	18	15	urinary	urinary	ADJ
ffhd-1631	18	16	tract	tract	NOUN
ffhd-1631	18	17	symptom	symptom	NOUN
ffhd-1631	18	18	score	score	NOUN
ffhd-1631	18	19	;	;	PUNCT
ffhd-1631	18	20	king	king	PROPN
ffhd-1631	18	21	’s	’s	PART
ffhd-1631	18	22	health	health	NOUN
ffhd-1631	18	23	questionnaire	questionnaire	NOUN
ffhd-1631	18	24	;	;	PUNCT
ffhd-1631	18	25	bioactive	bioactive	PROPN
ffhd-1631	18	26	compounds	compound	VERB
ffhd-1631	18	27	downloads	download	VERB
ffhd-1631	19	1	[	[	X
ffhd-1631	19	2	abstract	abstract	X
ffhd-1631	19	3	]	]	X
ffhd-1631	19	4	[	[	X
ffhd-1631	19	5	full	full	ADJ
ffhd-1631	19	6	article	article	NOUN
ffhd-1631	19	7	]	]	PUNCT
ffhd-1631	19	8	published	publish	VERB
ffhd-1631	19	9	2025	2025	NUM
ffhd-1631	19	10	-	-	SYM
ffhd-1631	19	11	06	06	NUM
ffhd-1631	19	12	-	-	PUNCT
ffhd-1631	19	13	04	04	NUM
ffhd-1631	19	14	issue	issue	NOUN
ffhd-1631	19	15	vol	vol	NOUN
ffhd-1631	19	16	.	.	PROPN
ffhd-1631	19	17	15	15	NUM
ffhd-1631	20	1	no	no	NOUN
ffhd-1631	20	2	.	.	NOUN
ffhd-1631	20	3	6	6	NUM
ffhd-1631	20	4	(	(	PUNCT
ffhd-1631	20	5	2025	2025	NUM
ffhd-1631	20	6	):	):	PUNCT
ffhd-1631	20	7	june	june	PROPN
ffhd-1631	20	8	2025	2025	NUM
ffhd-1631	20	9	section	section	NOUN
ffhd-1631	20	10	research	research	NOUN
ffhd-1631	20	11	articles	article	NOUN
ffhd-1631	20	12	license	license	VERB
ffhd-1631	20	13	copyright	copyright	NOUN
ffhd-1631	20	14	(	(	PUNCT
ffhd-1631	20	15	c	c	NOUN
ffhd-1631	20	16	)	)	PUNCT
ffhd-1631	20	17	2025	2025	NUM
ffhd-1631	20	18	functional	functional	ADJ
ffhd-1631	20	19	foods	food	NOUN
ffhd-1631	20	20	in	in	ADP
ffhd-1631	20	21	health	health	NOUN
ffhd-1631	20	22	and	and	CCONJ
ffhd-1631	20	23	disease	disease	NOUN
ffhd-1631	20	24	this	this	DET
ffhd-1631	20	25	work	work	NOUN
ffhd-1631	20	26	is	be	AUX
ffhd-1631	20	27	licensed	license	VERB
ffhd-1631	20	28	under	under	ADP
ffhd-1631	20	29	a	a	DET
ffhd-1631	20	30	creative	creative	ADJ
ffhd-1631	20	31	commons	common	NOUN
ffhd-1631	20	32	attribution	attribution	NOUN
ffhd-1631	20	33	-	-	PUNCT
ffhd-1631	20	34	noncommercial	noncommercial	ADJ
ffhd-1631	20	35	4.0	4.0	NUM
ffhd-1631	20	36	international	international	ADJ
ffhd-1631	20	37	license	license	NOUN
ffhd-1631	20	38	.	.	PUNCT
ffhd-1631	21	1	authors	author	NOUN
ffhd-1631	21	2	retain	retain	VERB
ffhd-1631	21	3	the	the	DET
ffhd-1631	21	4	copyright	copyright	NOUN
ffhd-1631	21	5	of	of	ADP
ffhd-1631	21	6	their	their	PRON
ffhd-1631	21	7	articles	article	NOUN
ffhd-1631	21	8	and	and	CCONJ
ffhd-1631	21	9	grant	grant	VERB
ffhd-1631	21	10	the	the	DET
ffhd-1631	21	11	functional	functional	ADJ
ffhd-1631	21	12	food	food	NOUN
ffhd-1631	21	13	center	center	NOUN
ffhd-1631	21	14	(	(	PUNCT
ffhd-1631	21	15	ffc	ffc	NOUN
ffhd-1631	21	16	)	)	PUNCT
ffhd-1631	21	17	and	and	CCONJ
ffhd-1631	21	18	its	its	PRON
ffhd-1631	21	19	journals	journal	NOUN
ffhd-1631	21	20	the	the	DET
ffhd-1631	21	21	right	right	NOUN
ffhd-1631	21	22	of	of	ADP
ffhd-1631	21	23	first	first	ADJ
ffhd-1631	21	24	publication	publication	NOUN
ffhd-1631	21	25	under	under	ADP
ffhd-1631	21	26	the	the	DET
ffhd-1631	21	27	terms	term	NOUN
ffhd-1631	21	28	of	of	ADP
ffhd-1631	21	29	the	the	DET
ffhd-1631	21	30	creative	creative	ADJ
ffhd-1631	21	31	commons	common	NOUN
ffhd-1631	21	32	attribution	attribution	NOUN
ffhd-1631	21	33	4.0	4.0	NUM
ffhd-1631	21	34	international	international	ADJ
ffhd-1631	21	35	license	license	NOUN
ffhd-1631	21	36	.	.	PUNCT
ffhd-1631	22	1	this	this	DET
ffhd-1631	22	2	license	license	NOUN
ffhd-1631	22	3	permits	permit	VERB
ffhd-1631	22	4	unrestricted	unrestricted	ADJ
ffhd-1631	22	5	use	use	NOUN
ffhd-1631	22	6	,	,	PUNCT
ffhd-1631	22	7	distribution	distribution	NOUN
ffhd-1631	22	8	,	,	PUNCT
ffhd-1631	22	9	and	and	CCONJ
ffhd-1631	22	10	reproduction	reproduction	NOUN
ffhd-1631	22	11	in	in	ADP
ffhd-1631	22	12	any	any	DET
ffhd-1631	22	13	medium	medium	NOUN
ffhd-1631	22	14	,	,	PUNCT
ffhd-1631	22	15	including	include	VERB
ffhd-1631	22	16	commercial	commercial	ADJ
ffhd-1631	22	17	use	use	NOUN
ffhd-1631	22	18	,	,	PUNCT
ffhd-1631	22	19	provided	provide	VERB
ffhd-1631	22	20	the	the	DET
ffhd-1631	22	21	original	original	ADJ
ffhd-1631	22	22	author(s	author(s	NOUN
ffhd-1631	22	23	)	)	PUNCT
ffhd-1631	22	24	and	and	CCONJ
ffhd-1631	22	25	source	source	NOUN
ffhd-1631	22	26	are	be	AUX
ffhd-1631	22	27	properly	properly	ADV
ffhd-1631	22	28	credited	credit	VERB
ffhd-1631	22	29	.	.	PUNCT
ffhd-1631	23	1	authors	author	NOUN
ffhd-1631	23	2	may	may	AUX
ffhd-1631	23	3	post	post	VERB
ffhd-1631	23	4	and	and	CCONJ
ffhd-1631	23	5	share	share	VERB
ffhd-1631	23	6	their	their	PRON
ffhd-1631	23	7	published	publish	VERB
ffhd-1631	23	8	work	work	NOUN
ffhd-1631	23	9	freely	freely	ADV
ffhd-1631	23	10	,	,	PUNCT
ffhd-1631	23	11	provided	provide	VERB
ffhd-1631	23	12	that	that	SCONJ
ffhd-1631	23	13	the	the	DET
ffhd-1631	23	14	original	original	ADJ
ffhd-1631	23	15	publication	publication	NOUN
ffhd-1631	23	16	in	in	ADP
ffhd-1631	23	17	this	this	DET
ffhd-1631	23	18	journal	journal	NOUN
ffhd-1631	23	19	is	be	AUX
ffhd-1631	23	20	acknowledged	acknowledge	VERB
ffhd-1631	23	21	.	.	PUNCT
ffhd-1631	24	1	by	by	ADP
ffhd-1631	24	2	submitting	submit	VERB
ffhd-1631	24	3	to	to	ADP
ffhd-1631	24	4	this	this	DET
ffhd-1631	24	5	journal	journal	NOUN
ffhd-1631	24	6	,	,	PUNCT
ffhd-1631	24	7	authors	author	NOUN
ffhd-1631	24	8	confirm	confirm	VERB
ffhd-1631	24	9	that	that	SCONJ
ffhd-1631	24	10	their	their	PRON
ffhd-1631	24	11	manuscripts	manuscript	NOUN
ffhd-1631	24	12	are	be	AUX
ffhd-1631	24	13	original	original	ADJ
ffhd-1631	24	14	,	,	PUNCT
ffhd-1631	24	15	not	not	PART
ffhd-1631	24	16	under	under	ADP
ffhd-1631	24	17	consideration	consideration	NOUN
ffhd-1631	24	18	elsewhere	elsewhere	ADV
ffhd-1631	24	19	,	,	PUNCT
ffhd-1631	24	20	and	and	CCONJ
ffhd-1631	24	21	that	that	SCONJ
ffhd-1631	24	22	they	they	PRON
ffhd-1631	24	23	hold	hold	VERB
ffhd-1631	24	24	the	the	DET
ffhd-1631	24	25	necessary	necessary	ADJ
ffhd-1631	24	26	rights	right	NOUN
ffhd-1631	24	27	to	to	PART
ffhd-1631	24	28	grant	grant	VERB
ffhd-1631	24	29	this	this	DET
ffhd-1631	24	30	license	license	NOUN
ffhd-1631	24	31	.	.	PUNCT
ffhd-1631	25	1	the	the	DET
ffhd-1631	25	2	functional	functional	ADJ
ffhd-1631	25	3	food	food	NOUN
ffhd-1631	25	4	center	center	NOUN
ffhd-1631	25	5	encourages	encourage	VERB
ffhd-1631	25	6	open	open	ADJ
ffhd-1631	25	7	scientific	scientific	ADJ
ffhd-1631	25	8	exchange	exchange	NOUN
ffhd-1631	25	9	and	and	CCONJ
ffhd-1631	25	10	allows	allow	VERB
ffhd-1631	25	11	derivative	derivative	ADJ
ffhd-1631	25	12	and	and	CCONJ
ffhd-1631	25	13	extended	extended	ADJ
ffhd-1631	25	14	works	work	NOUN
ffhd-1631	25	15	,	,	PUNCT
ffhd-1631	25	16	provided	provide	VERB
ffhd-1631	25	17	attribution	attribution	NOUN
ffhd-1631	25	18	to	to	ADP
ffhd-1631	25	19	the	the	DET
ffhd-1631	25	20	original	original	ADJ
ffhd-1631	25	21	publication	publication	NOUN
ffhd-1631	25	22	is	be	AUX
ffhd-1631	25	23	maintained	maintain	VERB
ffhd-1631	25	24	.	.	PUNCT
ffhd-1631	26	1	about	about	ADP
ffhd-1631	26	2	the	the	DET
ffhd-1631	26	3	journal	journal	NOUN
ffhd-1631	26	4	     	     	SPACE
ffhd-1631	26	5	editing	edit	VERB
ffhd-1631	26	6	services	service	NOUN
ffhd-1631	26	7	      	      	SPACE
ffhd-1631	26	8	graphical	graphical	ADJ
ffhd-1631	26	9	abstract	abstract	ADJ
ffhd-1631	26	10	     	     	SPACE
ffhd-1631	26	11	journal	journal	NOUN
ffhd-1631	26	12	insights	insight	NOUN
ffhd-1631	26	13	        	        	SPACE
ffhd-1631	26	14	submissions	submission	NOUN
ffhd-1631	26	15	        	        	SPACE
ffhd-1631	26	16	editorial	editorial	ADJ
ffhd-1631	26	17	team	team	NOUN
ffhd-1631	26	18	       	       	SPACE
ffhd-1631	26	19	privacy	privacy	NOUN
ffhd-1631	26	20	statement	statement	NOUN
ffhd-1631	26	21	        	        	SPACE
ffhd-1631	26	22	contact	contact	NOUN
ffhd-1631	26	23	        	        	SPACE
ffhd-1631	26	24	current	current	ADJ
ffhd-1631	26	25	        	        	SPACE
ffhd-1631	26	26	archives	archive	NOUN
ffhd-1631	26	27	  	  	SPACE
ffhd-1631	26	28	open	open	ADJ
ffhd-1631	26	29	journal	journal	NOUN
ffhd-1631	26	30	systems	system	NOUN
ffhd-1631	26	31	hosting	host	VERB
ffhd-1631	26	32	and	and	CCONJ
ffhd-1631	26	33	support	support	NOUN
ffhd-1631	26	34	by	by	ADP
ffhd-1631	26	35	:	:	PUNCT
ffhd-1631	26	36	openjournalsystems.com	openjournalsystems.com	X